M Botteman: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

PCN53 THE BURDEN OF MANAGING PLEURAL EFFUSIONS IN CML PATIENTS POST-IMATINIB FAILURE:A LITERATURE-BASED ECONOMIC ANALYSIS

JM Stephens, KT Carpiuc, MF Botteman, W Feng

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

52

PUK8 A REVIEW: DIFFERING COSTS AND EFFECTS IN ECONOMIC EVALUATIONS OF TOLTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER

SJ Snedecor, MF Botteman, D Weinstein, J Trocio

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

53

PUK6 FESOTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER—A COST-EFFECTIVENESS CASE STUDY OF SWEDEN

C Prütz, S Snedecor, M Botteman, J Trocio, D Weinstein

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

54

PDB36 ASSESSING THE IMPACT OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) OR POST-HERPETIC NEURALGIA (PHN) RELATED HEALTH IMPAIRMENT ON LOSS OF PRODUCTIVE TIME (LOPT)

NY Gu, C Bell, M Botteman, BA Van Hout

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

55

PND2 THE VALUE OF A PREDICTIVE DIAGNOSTIC BLOOD TEST IN MULTIPLE SCLEROSIS (MS)

BA Van Hout, M Botteman, A Dukler

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

56

MO1 IMPACT OF INCLUDING CARDIOVASCULAR AND RESPIRATORY OUTCOMES ON ESTIMATES OF CLINICAL AND ECONOMIC BENEFITS OF INFLUENZA VACCINATION IN THE U.S. ELDERLY POPULATION

X Gao, SJ Snedecor, O Ethgen, MF Botteman

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 85 KB

english, 2009

57

PMC39 A TRANSMISSION-DYNAMIC MODEL TO PREDICT THE INDIRECT BENEFITS OF INFANT VACCINATION WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7) TO OLDER POPULATIONS

S Snedecor, DR Strutton, V Ciuryla, EJ Schwartz, M Botteman

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 88 KB

english, 2009

58

PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER: APPLICATION TO THE UNITED KINGDOM

BG Verheggen, R Lee, MJ Treur, B Heeg, M Botteman, P Mollon, JN Trocio, T Bavendam, S Kaplan

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 88 KB

english, 2009

59

PCN74 COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID THERAPY FOR RENAL CELL CARCINOMA (RCC) PATIENTS WITH BONE METASTASES IN FRENCH, GERMAN, AND THE UK POPULATIONS

MF Botteman, S Kaura

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 94 KB

english, 2009

60

PCN78 COST-EFFECTIVENESS ASSESSMENT OF ZOLEDRONIC ACID (ZOL) RELATIVE TO PLACEBO (PBO) IN THE TREATMENT OF LUNG CANCER PATIENTS WITH SKELETAL METASTASES IN FIVE EUROPEAN COUNTRIES

MF Botteman, JFS Logman, S Kaura

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 84 KB

english, 2009

61

PMC34 SEROTYPE-SPECIFIC TRANSMISSION DYNAMICS OF INVASIVE PNEUMOCOCCAL DISEASE AFTER VACCINATION WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE

SJ Snedecor, MF Botteman, DR Strutton

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 81 KB

english, 2009

62

PSY20 COSTS AND COST DRIVERS OF IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA AND INHIBITORS

C Bojke, MF Botteman, CT Wilke, JM Stephens, B Kroner

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 99 KB

english, 2009

63

PEN6: COSTS OF TREATING NAIVE PATIENTS WITH TYPE 2 DIABETES—A COMPARISON BETWEEN THE UNITED KINGDOM AND FRANCE

CL Pashos, E Tafesse, M Botteman

Journal:

Value in Health

Year:

1999

Language:

english

File:

PDF, 75 KB

english, 1999

64

PHV21: PRELIMINARY ASSESSMENT OF THE ECONOMIC VALUE OF PERTUSSIS BOOSTER VACCINATION OF HOSPITAL STAFF

MF Botteman, CL Pashos, U Staginnus

Journal:

Value in Health

Year:

2000

Language:

english

File:

PDF, 57 KB

english, 2000

65

PHV17: PRELIMINARY ASSESSMENT OF THE ECONOMIC VALUE OF ADULT PERTUSSIS BOOSTER VACCINATION

MF Botteman, CL Pashos, U Staginnus

Journal:

Value in Health

Year:

2000

Language:

english

File:

PDF, 75 KB

english, 2000

66

TPS3: ESTIMATING THE VALUE OF DOUBLE READING IN MAMMOGRAPHY SCREENING

GN Semroc, MF Botteman, MT Dever

Journal:

Value in Health

Year:

1999

Language:

english

File:

PDF, 48 KB

english, 1999

67

PDD3: A COST-OF-TREATMENT MODEL FOR TYPE 2 DIABETES

JM Stephens, MF Botteman, JW Ramsdell, JA Grossman, R Arocho

Journal:

Value in Health

Year:

1999

Language:

english

File:

PDF, 70 KB

english, 1999

68

PCV18: COST EFFECTIVENESS OF ENOXAPARIN VS. UNFRACTIONATED HEPARIN FOR THE PROPHYLAXIS OF DVT AND SUBSEQUENT LONG-TERM COMPLICATIONS IN TOTAL HIP REPLACEMENT SURGERY IN THE UNITED KINGDOM

M Botteman, AT Cohen, V Nadipelli, J Stephens, CL Pashos, J Caprini

Journal:

Value in Health

Year:

2001

Language:

english

File:

PDF, 51 KB

english, 2001

69

AD3 A CONCEPTUAL FRAMEWORK THAT CAPTURES THE MULTIDIMENSIONAL ASPECT OF ADHERENCE IN A HEALTHECONOMIC MODEL: AN APPLICATION IN CHRONIC NONMALIGNANT PAIN MANAGEMENT

M Treur, NS Houwing, B Heeg, P Kristanto, M Botteman, P Vo, S Marx, E Lockhart, B Van Hout

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 99 KB

english, 2010

70

PCN71 A COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER IN 4 EUROPEAN COUNTRIES

M Botteman, J Carter, S Kaura

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

71

PCN32 COMPARING FORECASTED WITH ACTUAL BUDGET IMPACT: REIMBURSED CANCER DRUGS IN THE NETHERLANDS

PO Thuresson, B Heeg, M Botteman

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 70 KB

english, 2010

72

1146 POSTER Cost-effectiveness of zoledronic acid in the prevention of fractures in postmenopausal women with early breast cancer receiving aromatase inhibitor: Application to the United Kingdom

F. Logman, B. Heeg, M.F. Botteman, A.A. Marfatia, B.A. van Hout

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 63 KB

english, 2007

73

OP051 CHALLENGING OLD VIEWPOINTS: PARENTERAL NUTRITION (PN) AND THE RISK OF BLOODSTREAM INFECTION (BSI)

R.S. Turpin, C. Solem, M. Botteman, S. Mehta, A. Pontes-Arruda

Journal:

Clinical Nutrition Supplements

Year:

2012

Language:

english

File:

PDF, 63 KB

english, 2012

74

PP151-MON CHALLENGING OLD VIEWPOINTS: THE FREQUENCY OF PARENTERAL NUTRITION (PN) FORMULATION MODIFICATION

A. Pontes-Arruda, C. Solem, M. Botteman, S. Mehta, R.S. Turpin

Journal:

Clinical Nutrition Supplements

Year:

2012

Language:

english

File:

PDF, 54 KB

english, 2012

75

PRS29 Health Care Resource Utilization and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United States

A. Abudagga, S.X. Sun, H. Tan, A. Kavati, C.T. Solem, M.F. Botteman

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 74 KB

english, 2012

76

PRS19 Exacerbations and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United States

A. Abudagga, S.X. Sun, H. Tan, A. Kavati, C.T. Solem, M.F. Botteman

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

77

PMS91 Using Discrete Choice Experiments (DCE) to Estimate Preference-Based Utilities for Dupuytren's Contracture (DC)

N.Y. Gu, M. Botteman, R. Gerber, X. Ji, R. Postema, W. Wan, G. Sianos, I. Anthony, J.C. Cappelleri, P. Szczypa, B. Van Hout

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

78

PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone Therapies

C.T. Solem, C. Smith, P. Wiegand, M. Botteman, J. Germak, T. Wisniewski

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

79

PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

A. Marcellusi, M.F. Botteman, S. Rao, M. Cifaldi, C.T. Solem, L. Gitto, P. Giannantoni, F.S. Mennini

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

80

PCN72 Modeling the Survival Loss in Patients With Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP) Switched from Imatinib Mesylate to a Generic Copy

M. Botteman, M. Magestro, A.F. Alwan

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

81

PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

M.F. Botteman, J.A. Carter, P. Fishman, D. Chandiwana, M. Bains, S.J. Snedecor

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

82

Underprescribing angiotensin converting enzyme inhibitors in heart failure: a missed economic opportunity

Stephanie K. Hauser, Marc F. Botteman, Joseph A. Gricar, Zoe Kopp, Chris L. Pashos, Harlan M. Krumholz

Journal:

Journal of the American College of Cardiology

Year:

2002

Language:

english

File:

PDF, 146 KB

english, 2002

83

PHP34 ECONOMICS OF TRANSFUSION

JM Yeh, MF Botteman, CL Pashos, MJ Postma, U Staginnus

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 60 KB

english, 2002

84

PHP40 COST EFFECTIVENESS OF PATHOGEN INACTIVATION IN PLATELET TRANSFUSIONS

C Bell, J Weissfeld, M Botteman, D Gregory, U Staginnus, C Pashos

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 63 KB

english, 2002

85

PCV25 THE ECONOMIC IMPACTS OF TROUGH: PEAK RATIO AND LIPOPHILICITY ON COST-EFFECTIVENESS OF ACE-INHIBITOR THERAPY FOR HYPERTENSION

EL Keuffel, M Cifaldi, MF Botteman

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 62 KB

english, 2002

86

PDB5 THE ECONOMIC VALUE OF NON-DIHYDROPYRIDINE VS. DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER/ACE INHIBITOR COMBINATIONS IN PATIENTS WITH TYPE-II DIABETES

EL Keuffel, M Cifaldi, MF Botteman

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 66 KB

english, 2002

87

PDB8 ECONOMIC COMPARISON OF SIX FIRST-LINE DRUG STRATEGIES IN TYPE 2 DIABETES USING A MONTE CARLO SIMULATION MODEL

JM Stephens, JW Ramsdell, S Braunstein, CF Bell, MF Botteman, S Brandt, ST Devine

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 61 KB

english, 2002

88

PIN5 COST-EFFECTIVENESS OF VACCINATING ADULT CLOSE CONTACTS WITH BOOSTRIX®

TB Kornfield, MF Botteman, C Pashos

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 81 KB

english, 2002

89

PMI32 EVALUATING THE USE OF PROBABILISTIC SENSITIVITY ANALYSIS VIA MONTE CARLO SIMULATION (MCS): AN AUDIT OF THE HEALTH ECONOMIC LITERATURE

M Botteman, C Bell, J Stephens

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 76 KB

english, 2002

90

PMW4 DEVELOPING A BETTER UNDERSTANDING OF COST-EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY (HRT): A COMPREHENSIVE REVIEW OF ECONOMIC ANALYSIS FROM 1980 TO 2001

NP Shah, MF Botteman, KF Gold, J Brandman

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 62 KB

english, 2002

91

PMD6 MODIFYING COST-EFFECTIVENESS RATIOS TO BE MAXIMALLY COMPARABLE ACROSS MULTIPLE DISEASES:AN APPLICATION OF MANIFOLD THEORY

K Gold, M Botteman, C Pashos

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 78 KB

english, 2002

92

AR1 ASSESSING THE COST-EFFECTIVENESS OF COX-2 SPECIFIC INHIBITORS FOR ARTHRITIS IN THE VETERANS HEALTH ADMINISTRATION

M Schaefer, ML DeLattre, X Gao, JM Stephens, MF Botteman, A Morreale

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 56 KB

english, 2004

93

CN2 7215 COST-EFFECTIVENESS OF DIAGNOSTIC, STAGING, AND TREATMENT OPTIONS FOR MELANOMA

YE Chavez, WC Lee, MF Botteman, CL Pashos

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 71 KB

english, 2004

94

PCN30 USING THE DIFFERENCE IN DIFFERENCE METHOD TO UNDERSTAND OUTCOMES IN PROSTATE CANCER

WC Lee, CL Pashos, J Brandman, Q Wang, MF Botteman

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 45 KB

english, 2004

95

PMH23 COST-EFFECTIVENESS EVALUATION OF LONG-ACTING RISPERIDONE INJECTION

N Edwards, M Rupnow, CL Pashos, MF Botteman, J Locklear, R Diamond

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 46 KB

english, 2004

96

PUK2 A COST COMPARISON ANALYSIS OF TWO CLINICALLY UROSELECTIVE ALPHA BLOCKERS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

MF Botteman, FC Lowe, M Naslund, J Sollano, CL Pashos, M Litwin

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 48 KB

english, 2004

97

PNL29 COST-EFFECTIVENESS OF LONGER-TERM TREATMENT WITH ESZOPICLONE 3MG IN ADULTS WITH PRIMARY INSOMNIA

M Botteman, R Ozminkowski, S Wang, CL Pashos, DJ Foley, K Schaefer

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 62 KB

english, 2005

98

PDB34 NEEDLESTICK INJURY IN NURSES CARING FOR PATIENTS WITH DIABETES

CL Pashos, L Nicklasson, JM Lee, MF Botteman, D Cobden

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 67 KB

english, 2005

99

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE

M Botteman, M Aapro, J Stephens, JW Hay, J Brandman

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

100

PCN10 ECONOMIC IMPACT OF PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME IN PATIENTS WITH HORMONEREFRACTORY PROSTATE CANCER

P Mulani, M Botteman, JW Hay, M Cifaldi

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 69 KB

english, 2005